eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 14
Basic research

Sequencing of exons 4, 5, 12 of COCH gene in patients with postlingual sensorineural hearing loss accompanied by vestibular lesion

Marzena Mielczarek, Jurek Olszewski, Piotr Pietkiewicz

Arch Med Sci 2018; 14, 3: 625–628
Online publish date: 2016/05/20
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Mutations at the DFNA9 locus on chromosome 14q12 are the third most common form of DFNA hearing loss, which is clinically characterized by late onset (in adulthood) progressive sensorineural hearing loss accompanied by vestibular dysfunction. The aim of the study was to search for COCH gene mutations (P51S, V66G, G87W, G88E, V104del, I109N, W117R, A119T, M512T, C542Y) in patients with severe or profound sensorineural hearing loss accompanied by a vestibular lesion.

Material and methods
The study was based on a group of 30 patients. Qualification criteria comprised the presence of progressive postlingual, severe to profound sensorineural hearing loss with tinnitus, early age of sensorineural hearing loss onset, before the 40th year of life, and a positive family history of early onset hearing loss. All patients were diagnosed with peripheral vestibular lesions.

The authors did not find P51S, V66G, G87W, G88E, V104del, I109N, W117R, A119T, M512T, or C542Y mutations in the COCH gene in the tested group (no differences were found in the nucleotide sequences of exomes 4, 5 and 12 when compared to the published cDNA sequence of the COCH gene).

No cochlin mutations were found in the group of patients with severe to profound sensorineural hearing impairment accompanied by a vestibular lesion. The COCH gene needs further exploration and analysis of genotype-phenotype correlations.


postlingual sensorineural hearing loss, vestibular lesion, COCH gene

Quaranta N, Coppola F, Casulli M, et al. The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults. Audiol Neurootol 2014; 19 Suppl 1: 10-4.
Van Camp G, Smith RJH. Hereditary Hearing Loss Homepage. http://hereditaryhearingloss.org
Hildebrand MS, Gandolfo L, Shearer AE, et al. A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss. Laryngoscope 2010; 120: 2489-93.
Chen DY, Chai YC, Yang T, Wu H. Clinical characterization of a novel COCH mutation G87V in a Chinese DFNA9. Int J Pediatr Otorhinolaryngol 2013; 77: 1711-5.
Robertson NG, Hamaker SA, Patriub V, Aster JC, Morton CC. Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet 2003; 40: 479-86.
Bhattacharya SK. Focus on molecules: cochlin. Exp Eye Res 2006; 82: 355-6.
Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
Yao J, Py BF, Zhu H, Yuan J, Bao J. Role of protein misfolding in DFNA9 hearing loss. J Biol Chem 2010; 285: 14909-19.
Khetarpal U, Schuknecht HF, Gacek RR, Holmes LB. Autosomal dominant sensorineural hearing loss. Pedigrees, audiologic findings, and temporal bone findings in two kindreds. Arch Otolaryngol Head Neck Surg 1991; 117: 1032-42.
Khetarpal U. Autosomal dominant sensorineural hearing loss. Further temporal bone findings. Arch Otolaryngol Head Neck Surg 1993; 119: 106-8.
Robertson NG, Cremers CW, Huygen PL, et al. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet 2006; 15: 1071-85.
Fransen E, Verstreken M, Verhagen WIM, et al. High prevalence of symptoms of Meniere’s disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999; 8: 1425-9.
Kommareddi PK, Nair TS, Raphael Y, et al. Cochlin isoforms and their interaction with CTL2 (SLC44A2) in the inner ear. JARO 2007; 8: 435-46.
Saracyn M, Płoski R, Niemczyk S. Contemporary role of medical genetics in internal medicine. Arch Med Sci 2013; 9: 594-600.
Liggett SB, Stephen B. Pharmacogenetic applications of the Human Genome project. Nat Med 2001; 7: 281-3.
Sanchez E, López-Escámez JA, López-Nevot MA, López-Nevot A, Cortes R, Martin J. Absence of COCH mu­tations in patients with Meniere disease. Eur J Hum Genet 2004; 12: 75-8.
Usami S, Takahashi K, Yuge I, et al. Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Meniere’s disease. Eur J Hum Genet 2003; 11: 744-8.
Street V, Kallman J, Strombom P, Bramhall N, Phillips J. Vestibular function in families with inherited autosomal dominant hearing loss. J Vestib Res 2008; 18: 51-8.
Gallant E, Francey L, Fetting H, et al. Novel COCH mutation in a family with autosomal dominant late onset sensorineural hearing impairment and tinnitus. Am J Otolaryngol 2013; 34: 230-5.
Street VA, Kallman JC, Robertson NG, Kuo SF, Morton CC, Phillips JO. A novel DFNA9 mutation in the vWFA2 domain of COCH alters a conserved cysteine residue and intrachain disulfide bond formation resulting in progressive hearing loss and site-specific vestibular and central oculomotor dysfunction. Am J Med Genet 2005; 139A: 86-95.
Vermeire K, Brokx JP, Wuyts FL, et al. Good speech recognition and quality-of-life scores after cochlear implantation in patients with DFNA9. Otol Neurotol 2006; 27: 44-9.
Eppsteiner RW, Shearer AE, Hildebrand MS, et al. Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. Hear Res 2012; 292: 51-8.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe